Clinical Trials Browser

Phase 1 × Withdrawn × asparaginase erwinia chrysanthemi recombinant × Clear all

NCT02647190 2017-06-02

Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma